✦ LIBER ✦

1.292 Beneficial impact of pramipexole on social functioning in patients with restless legs syndrome

✍ Scribed by T. Zesiewicz; J. Köster; S. Albrecht; E. Lainey

Book ID: 117752768
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 57 KB
Volume: 13
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(08)70527-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of pramipexole on cutaneous-silen

Effect of pramipexole on cutaneous-silent-period parameters in patients with restless legs syndrome

✍ Oğuzhan Öz; Çağdaş Erdoğan; Mehmet Yücel; Hakan Akgün; Yaşar Kütükçü; Zeki Gökçi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 595 KB

1.290 Effect of patient age on pramipexo

1.290 Effect of patient age on pramipexole efficacy in the treatment of restless legs syndrome

✍ T. Zesiewicz; E. Lainey; J. Köster; S. Albrecht 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Long-term open-label study of pramipexol

Long-term open-label study of pramipexole in patients with primary restless legs syndrome

✍ Yuichi Inoue; Kenji Kuroda; Koichi Hirata; Naohisa Uchimura; Tatsuo Kagimura; Te 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Controlled withdrawal of pramipexole aft

Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome

✍ Claudia Trenkwalder; Karin Stiasny-Kolster; Andreas Kupsch; Wolfgang H. Oertel; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract Although dopamine agonists are becoming first‐line therapy for restless legs syndrome (RLS), few reports describe treatment periods exceeding 12 weeks. Here, 150 RLS patients who had responded to pramipexole during a 6‐month run‐in period (mean dose, 0.50 mg) were randomly assigned to r

The prevalence and impact of restless le

The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia

✍ Allen, Richard P.; Auerbach, Sarah; Bahrain, Huzefa; Auerbach, Michael; Earley, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

1.287 Effectiveness of pramipexole in th

1.287 Effectiveness of pramipexole in the treatment of RLS: A 12-weeks non-interventional trial in patients with primary restless legs syndrome (RLS)

✍ C. Möller; I. Eisensehr; J. Köster; R. Kohnen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB